Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.22
Bid: 2.13
Ask: 2.29
Change: -0.01 (-0.45%)
Spread: 0.16 (7.512%)
Open: 2.22
High: 2.22
Low: 2.20
Prev. Close: 2.22
QED Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RESULT OF RUMP PLACING

10 Dec 2009 09:13

RNS Number : 9016D
Quintain Estates & Development PLC
10 December 2009
 



This announcement (and the information contained herein) is not for release, publication or distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States and the district of Columbia), AustraliaCanada,South Africa or Japan.

10 December 2009

Quintain Estates and Development plc ("Quintain" or the "Company")

RESULT OF RUMP PLACING

Quintain announced earlier today that, as at 11.00 a.m. on 9 December 2009, being the latest date and time for receipt of valid subscriptions, it had received valid acceptances in respect of 383,949,664 New Ordinary Shares, representing approximately 98.41 per cent of the total number of New Ordinary Shares offered to Shareholders pursuant to the 3 for 1 Rights Issue announced on 5 November 2009.

Quintain now announces that J.P. Morgan Cazenove Limited has procured subscribers for the remaining6,210,632 New Ordinary Shares for which valid acceptances were not received, at a price of 60 pence per New Ordinary Share.

The net proceeds after deduction of the Issue Price of 49 pence per New Ordinary Share and the expenses of procuring subscribers will be paid to those shareholders that have not taken up their entitlements pro rata to their lapsed provisional allotments, except that individual amounts of less than £5.00 will not be paid to such persons but will be retained and will ultimately accrue for the benefit of the Company.

Capitalised terms used, but not defined, in this announcement shall have the same meanings as given to them in the Prospectus relating to the Rights Issue dated 5 November 2009. 

ENQUIRIES: 

Quintain Estates and Development plc

+44 (0) 20 7495 8968

Rebecca Worthington / Cressida Curtis

J.P. Morgan Cazenove Limited

+44 (0) 20 7588 2828

Robert Fowlds / Bronson Albery / Andrew Wray

Lazard & Co., Limited

+44 (0) 20 7187 2000

Paul Gismondi / Patrick Long

Financial Dynamics

+44 (0) 20 7831 3113

Stephanie Highett / Dido Laurimore /  

Laurence Jones

IMPORTANT NOTICE:

This announcement does not constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security.

This announcement is an advertisement and does not constitute a prospectus or prospectus equivalent document. Nothing in this announcement should be interpreted as a term or condition of the Rights Issue. Any decision to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any Provisional Allotment Letter, Nil Paid Rights, Fully Paid Rights, and/or New Ordinary Shares must be made only on the basis of the information contained in and incorporated by reference into the Prospectus.

This announcement does not constitute or form part of any offer or solicitation to purchase or subscribe for securities in the United StatesThe securities referred to herein may not be offered or sold in the United States absent registration, or an exemption from registration, under the US Securities Act of 1933, as amended (the "Securities Act"), or an exemption from, or in a transaction not subject to, registration. The Company has not registered and does not intend to register any securities under the Securities Act. There will be no public offering of the securities in the United StatesSubject to certain exceptions, the securities referred to herein may not be offered or sold in AustraliaCanada or, Japan or to, or for the account or benefit of, any national, resident or citizen of AustraliaCanada or Japan. The offer and sale of the securities referred to herein has not been and will not be registered under the applicable securities laws of AustraliaCanadaSouth Africa or Japan.

Each of J.P. Morgan Cazenove Limited, J.P. Morgan Securities Ltd., Lazard & Co., Limited, HSBC Bank plc and Barclays Bank PLC (together, the "Banks") is acting exclusively for Quintain in connection with the Rights Issue. None of the Banks will regard any other person as their client in relation to the Rights Issue and will not be responsible to anyone other than Quintain for providing the protections afforded to their respective clients nor for the giving of advice in relation to the Rights Issue.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIGUGGGPUPBUBU
Date   Source Headline
26th Jun 20247:00 amRNSExtended agreement with BTG Bioliquids for bioMSAR
29th May 20247:00 amRNSRepresentation Agreement Addendum & Warrants Grant
28th May 20247:00 amRNSOCP Commercial Framework Agreement
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company
15th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.